Prodromal Parkinson's Disease

Prodromal Parkinson's Disease
Kiel, Germany – June 14-15, 2019

Prodromal Parkinson's Disease takes place in Kiel, Germany, June 14-15, 2019.Course Directors

Daniela Berg, MD, PhD, Christian-Albrechts University Kiel, Germany
Matej Skorvanek MD, PhD, University of P. J. Safarik in Kosice, Slovakia
Eva Schäffer, MD, Christian-Albrechts, University Kiel, Germany

Course Description

The concept of Prodromal Parkinson’s disease (PD) is gaining increased attention as it has become evident that there are several risk and clinical markers (prodromal markers) that may occur years before the cardinal motor symptoms allow clinical diagnosis. The hope for an earlier diagnosis as basis for early therapeutic intervention has become even more meaningful in the light of the current development of causal therapies including antibody and anti-oxidative therapies as well as specific approaches for mono-genetic forms of PD. A statistical model has been developed that allows the calculation of the individual risk to develop PD.

These new concepts, their backgrounds, implementation, chances and possible confounders and limitations need to be understood and properly applied.

This course is intended for neurologists, residents in neurology and basic scientists interested in prodromal PD. During the course, evidence-based results and speakers’ experiences with risk and prodromal markers, cohorts, assessments and calculations in prodromal PD, as well as emerging treatments will be reviewed from the basic science as well as clinical point of view. The course will also include hands-on sessions on several aspects of prodromal PD assessment. The meeting will be concluded with an interactive panel discussion on future steps. Poster presentations will allow participants presentation of their recent work in the field of prodromal PD and discussion of novel ideas.

Recommended Audience

This course is intended for neurologists, residents in neurology and basic scientists interested in prodromal PD.

Learning Objectives 
  • Recognize the currently known risk and prodromal markers of prodromal PD
  • Discuss the possible approaches to identify individuals in the prodromal phase
  • Discuss the emerging treatment strategies for prodromal PD

 

Venue

 

University of Kiel, Department for Neurology
Kiel, Germany

Visa Statement

MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official handling your application needs further clarification, please have them contact education@movementdisorders.org.



dpg logo


This course is presented in collaboration with The German Society for Parkinson’s Disease (DPG).

 

Registration Opens Soon

Member: $200 USD
Non-Member: $250 USD
Junior/Waived Dues Member: $150 USD

Registration includes entrance to all sessions, course materials, catering, and 1-year associate membership for eligible non-members.  To find out more about associate membership or eligibility, please visit the Associate Membership webpage.

 

Travel Bursary Application

Deadline to apply is March 1, 2019

***
Join this course's Facebook Event.*

*Please note you must also register (when open) in addition to joining the event.

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. The MDS site uses multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice